Measurement differences explain much of the variation in adherence and persistence after ischemic stroke, and standardized estimates are lower: a systematic review with meta-regression.
OBJECTIVE Continued use of secondary prevention medications after ischemic stroke or transient ischemic attack is an important component of long-term management. Reported estimates of adherence and persistence vary considerably across studies, limiting comparison and interpretability. Although some variation may reflec...